期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

前列腺癌相关生物标志物研究新进展 被引量：2

原文传递
导出
摘要 前列腺癌是世界上第二大男性肿瘤，在男性致死性肿瘤中排第六位。2008年全世界前列腺癌新发病例约899000例，死亡病例约258000例，其中72％的新发病例和53％的死亡病例发生在欧洲、北美等发达国家。亚洲地区的前列腺癌发病率在世界范围是最低的，然而近年也有明显上升趋势。
作者 高巍 滕梁红
机构地区 首都医科大学宣武医院病理科
出处 《中华病理学杂志》 CAS CSCD 北大核心 2013年第7期487-490,共4页 Chinese Journal of Pathology
关键词 前列腺癌 生物标志物 男性肿瘤 世界范围 新发病例 死亡病例 发达国家 癌发病率
分类号 R737.25 [医药卫生—肿瘤]
  • 相关文献

参考文献38

  • 1Center MM, Jemal variation in prostate A, Lortet-Tieulent J, cancer incidence and et al. International mortality rates. Eur Urol, 2012,61 (6) : 1079-1092. 被引量：1
  • 2Cullen J, Elsamanoudi S, Brassell SA, et al. The burden of prostate cancer in Asian nations. J Carcinog, 2012,11:7. 被引量：1
  • 3Nogueira L, Corradi R, Eastham JA. Prostatic specific antigen for prostate cancer detection. Int Braz J Uml, 2009,35 (5) :521-529; discussion 530-522. 被引量：1
  • 4Lilja H, Ulmert D, Vickers AJ. Prostate-specific antigen and prostate cancer: prediction, detection and monitoring. Nat Rev Cancer, 2008,8(4) :268-278. 被引量：1
  • 5Stephan C, Cammann H, Meyer HA, et al. PSA and new biomarkers within multivariate models to improve early detection of prostate cancer. Cancer Lett, 2007,249 ( 1 ) : 18-29. 被引量：1
  • 6Steuber T, O' Brien MF, Lilja H. Serum markers for prostate cancer: a rational approach to the literature. Eur Urol, 2008,54 (1) :31-40. 被引量：1
  • 7Steuber T, Vickers A J, Serio AM, et al. Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer. Clin Chem, 2007,53(2) :233-240. 被引量：1
  • 8Uetsuki H, Tsunemori H, Taoka R, et al. Expression of a novel biomarker, EPCA, in adenocarcinomas and precancerous lesions in the prostate. J Urol, 2005,174(2) :514-518. 被引量：1
  • 9Leman ES, Cannon GW, Trock BJ, et al. EPCA-2: a highly specific serum marker for prostate cancer. Urology, 2007,69(4) : 714-720. 被引量：1
  • 10Sreekumar A, Laxman B, Rhodes DR, et al. Humoral immune response to alpha-methylacyl-CoA racemase and prostate cancer. J Natl Cancer Inst, 2004,96( 11 ) :834-843. 被引量：1

二级参考文献12

  • 1陈占国,陶志华,陈晓东,李澄棣,余志贤,李湘斌,杨建荣.前列腺癌特异性基因DD3在前列腺癌患者外周血中表达的意义[J].中华泌尿外科杂志,2005,26(12):806-808. 被引量：5
  • 2翁志梁,余凯远,毛晓露,陶志华,陈晓东,吴秀玲,胡元平,王思齐,李澄棣,陈占国.外周血差异显示编码3mRNA定量检测在前列腺癌患者诊断与治疗监测中的初步应用[J].中华医学杂志,2006,86(41):2911-2915. 被引量：9
  • 3张黎明,章祖招,张鑫圣,吴晓宇,李招云.SYBR GreenⅠ实时RT-PCR定量检测前列腺癌患者外周血DD3mRNA[J].中国实验诊断学,2007,11(10):1374-1377. 被引量：4
  • 4Bussemakers MJ,Bokboven AV,Verhaegh GW. DD3:a new prostate-specific gene,highly overexpressed in prostate cancer[J].Cancer Research,1999.5975-5979. 被引量：1
  • 5De Kok JB,Verhaegh GW,Roelofs RW. DD3 (PCA3),a very sensitive and specific marker to detect prostate tumors[J].Cancer Research,2002.2695-2698. 被引量：1
  • 6Oliveira JDD,Goulart LR,Waldesse POJ. DD3 gene expression in peripheral blood of patients with prostate cancer and with benign prostate hyperplasia as a molecular diagnostic[J].European Urology Supplements,2003.102.doi:10.1016/S1569-9056(03)90463-5. 被引量：1
  • 7Marangoni K,Neves AF,Cardoso AM. The endothelial nitric oxide synthase Glu-298-Asp polymorphism and its mRNA expression in the peripheral blood of patients with prostate cancer and benign prostatic hyperplasia[J].Cancer Detection and Prevention,2006.7-13.doi:10.1016/j.cdp.2005.09.004. 被引量：1
  • 8V(a)(a)n(a)nen RM,Rissanen M,Kauko O. Quantitative realtime RT-PCR assay for PCA3[J].Clinical Biochemistry,2008.103-108. 被引量：1
  • 9Hessels D,Klein Gunnewiek JMT,Oort IV. DD3PCA3based molecular urine analysis for the diagnosis of prostate cancer[J].European Urology,2003.8-16. 被引量：1
  • 10Groskopf J,Sheila M J,Deras IL. APTIMA PCA3 molecular urine test:development of a method to aid in the diagnosis of prostate cancer[J].Clinical Chemistry,2006,(6):1089-1095.doi:10.1373/clinchem.2005.063289. 被引量：1

共引文献20

同被引文献28

  • 1王慕文,金讯波,赵勇,蒋绍博,李昕,夏庆华,熊晖,孙鹏,陈修德,王正.^11C-胆碱PET／CT显像在前列腺癌诊断中的应用价值[J].中华泌尿外科杂志,2007,28(1):53-56. 被引量：7
  • 2那彦群,叶章群,孙颖浩,等.中国泌尿外科疾病诊断治疗指南[M].北京:人民卫生出版社,2013:439. 被引量：49
  • 3REITER RE, GU Z, WATA BE, et al. Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer[J]. Proc Natl Acad Sci USA, 1998,95(4): 1735-1740. 被引量：1
  • 4PETRIGLIANO FA, VIRK MS, LIU N, et al. Targeting of prostate cancer cells by a cytotoxic lentiviral vector containing a prostate stem cell antigen(psca) promoter[J]. Prostate,2009,69(13):1422-1434. 被引量：1
  • 5EPSTEIN JI,ALLSBROOK WC,AMIN MB,et al.The 2005 International Society of Urological Pathology(ISUP) consensus conference on gleason grading of prostatic carcinoma[J]. Am J Surg Pathol,2005,29(9): 1228-1242. 被引量：1
  • 6BRINKER DA,POTTER SR,EPSTEIN JI. Ductal adencarcinoma of the prostate diagnosed on needle biopy: correlation with clinical and radical prostatectomy findings and progression[J]. Am J Surg Pathol, 1999,23:1471-1479. 被引量：1
  • 7BARBISAN F, MAZZUCCHELLI R, SANTINELLI A, et al. Expression of prostate stem cell antigen in high-grade prostatic intraepithelial neoplasia and prostate cancer[J]. Histopathology, 2010,57(4):572-579. 被引量：1
  • 8ANTONARAKIS ES, CARDUCCI MA, EISENBERGER MA, et al. Phase I rapid dose-escalation study of AGS-1C4D4, a human anti-PSCA (prostate stem cell antigen) monoclonal antibody, in patients with castration-resistant prostate cancer: a PCCTC trial[J]. Cancer Chemother Pharmacol, 2012,69(3):763-771. 被引量：1
  • 9ZHAO Z, MA W,ZENG G, et al. Small interference RNA-mediated silencing of prostate stem cell antigen attenuates growth, reduces migration and invasion of human prostate cancer PC-3M cells[J]. Urol Onco,2011,2(4):1-9. 被引量：1
  • 10MOORE ML, TEITELL MA, Kim Y, et al. Deletion of PSCA increases metastasis of TRAMP-induced prostate tumor without altering primary tumor formation[J]. Prostate, 2008,68(2):139-151. 被引量：1

引证文献2

二级引证文献11

中华病理学杂志
2013年 第7期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部